Hematology-Oncology Associates of CNY has appointed Jennifer Pichoske as chief executive officer effective February 15, 2025.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Bristow's report suggests that the current share price does not account for the potential success of subsequent programs, including those for head and neck squamous cell carcinoma (HNSCC), ...

Reston Hospital Center, a part of US-based healthcare network HCA Virginia, has opened an inpatient unit at its main hospital ...

Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

MidAmerica Cancer Care (MACC), a trusted name in Kansas City and western Missouri cancer care, is proud to announce it has ...

Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...

In a report released today, Roger Song from Jefferies maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target of ...

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Oncology practices at Olean General Hospital's Barry Street Health Center and at Bradford Regional Medical Center have received recertification by the Association for Clinical Oncology, an affiliate o ...